Liang Xia, Zeng Xian-Tao, Hong Zhi-Liang, Su Miao-Jiao, Yang Jian-Chuan, Wu Song-Song
Fujian Provincial Hospital, Provincial Clinical Medical College, Fujian Medical University, Fuzhou, China.
Fujian Provincial Hospital, Fujian Provincial Key Laboratory of Critical Care Medicine, Fuzhou, China.
Front Oncol. 2024 Dec 13;14:1446801. doi: 10.3389/fonc.2024.1446801. eCollection 2024.
This study aims to assess the diagnostic efficacy of conventional ultrasound (CUS) and contrast-enhanced ultrasound (CEUS) in detecting fat-poor angiomyolipomas(AML) with dimensions less than 5 cm. Additionally, the study seeks to identify independent indicators for predicting the presence of fat-poor AML.
We conducted a retrospective analysis of patients diagnosed with renal AML and renal cell carcinoma, who were admitted and underwent surgery at Fujian Provincial Hospital from January 2013 to October 2023. A total of 154 renal tumors were included (104 renal cell carcinomas and 50 fat-poor AMLs). Prior to radical or partial nephrectomy, these patients underwent both CUS and CEUS examinations. We systematically analyzed the features observed in CUS and CEUS, identified independent factors through multifactorial regression analysis, and evaluated diagnostic efficacy by calculating the area under the curve (AUC).
Univariate analysis revealed significant distinctions in fat-poor AML concerning gender, age, morphology, internal hyperechoic features (starry-sky sign, crescent sign), enhancement uniformity, and delayed enhancement, all displaying significance compared to renal cell carcinoma (RCC) ( < 0.05). Multivariate analysis demonstrated that internal hyperechoic features ( < 0.01, Odds Ratio [OR] = 0.003, 95% Confidence Interval [CI]: 0.000-0.0028) and enhancement uniformity ( < 0.01, OR = 0.016, 95% CI: 0.001-0.229) independently predicted fat-poor AML. The Receiver Operating Characteristic (ROC) curve's area under the curve (AUC) for internal hyperechoic features (starry-sky sign, crescent sign) was 0.88 (95% CI: 0.80-0.95), with a sensitivity of 78.00%, specificity of 97.12%, positive predictive value of 92.85%, and negative predictive value of 90.18%. Conversely, the ROC curve AUC for enhancement uniformity was 0.70 (95% CI: 0.62-0.78), with a sensitivity of 96.00%, specificity of 44.23%, positive predictive value of 45.28%, and negative predictive value of 95.83%.
This study suggests that both CUS and CEUS possess discriminative value in differentiating fat-poor AMLs from RCCs. Notably, internal hyperechoic features (starry-sky sign, crescent sign) and uniform enhancement within renal tumors emerge as potential independent indicators for predicting fat-poor AML.
本研究旨在评估传统超声(CUS)和超声造影(CEUS)在检测直径小于5 cm的乏脂性肾血管平滑肌脂肪瘤(AML)中的诊断效能。此外,该研究还试图确定预测乏脂性AML存在的独立指标。
我们对2013年1月至2023年10月在福建省立医院住院并接受手术的诊断为肾AML和肾细胞癌的患者进行了回顾性分析。共纳入154例肾肿瘤(104例肾细胞癌和50例乏脂性AML)。在根治性或部分肾切除术前,这些患者均接受了CUS和CEUS检查。我们系统分析了CUS和CEUS观察到的特征,通过多因素回归分析确定独立因素,并通过计算曲线下面积(AUC)评估诊断效能。
单因素分析显示,乏脂性AML在性别、年龄、形态、内部高回声特征(星空征、新月征)、增强均匀性和延迟增强方面与肾细胞癌(RCC)相比有显著差异(<0.05)。多因素分析表明,内部高回声特征(<0.01,优势比[OR]=0.003,95%置信区间[CI]:0.000-0.0028)和增强均匀性(<0.01,OR=0.016,95%CI:0.001-0.229)可独立预测乏脂性AML。内部高回声特征(星空征、新月征)的受试者操作特征(ROC)曲线下面积(AUC)为0.88(95%CI:0.80-0.95),敏感性为78.00%,特异性为97.12%,阳性预测值为92.85%,阴性预测值为90.18%。相反,增强均匀性的ROC曲线AUC为0.70(95%CI:0.62-0.78),敏感性为96.00%,特异性为44.23%,阳性预测值为45.28%,阴性预测值为95.83%。
本研究表明,CUS和CEUS在区分乏脂性AML和RCC方面均具有鉴别价值。值得注意的是,肾肿瘤内部的高回声特征(星空征、新月征)和均匀增强是预测乏脂性AML潜在的独立指标。